Table 3.
Significant PET findings between groups.
| S+N+C (n = 11): Group A | N+C (n = 11): Group B | S (n = 11): Group C | Normal (n = 11): Group D | P | Post Hoc P | |
|---|---|---|---|---|---|---|
| Mid-frontal L | 0.88 ± 0.07 | 0.93 ± 0.04 | 0.91 ± 0.04 | 0.97 ± 0.06 | .052 | A/D: .019, C/D: .054 |
| Mid-frontal R | 0.90 ± 0.08 | 0.95 ± 0.05 | 0.94 ± 0.04 | 1.00 ± 0.06 | .022* | A/D: .006, B/D: .079, C/D: .029 |
| Mid-orbitofrontal L | 0.84 ± 0.08 | 0.92 ± 0.05 | 0.90 ± 0.03 | 0.94 ± 0.07 | .051 | A/B: .021, A/C: .054, A/D: .023 |
| Inferior orbitofrontal R | 0.87 ± 0.07 | 0.91 ± 0.06 | 0.93 ± 0.03 | 0.94 ± 0.04 | .032* | A/C: .015, A/D: .011 |
| Posterior cingulum L | 0.89 ± 0.07 | 0.92 ± 0.06 | 0.89 ± 0.04 | 0.97 ± 0.07 | .075 | A/D: .028, C/D: .049 |
| Posterior cingulum R | 0.80 ± 0.09 | 0.83 ± 0.07 | 0.80 ± 0.03 | 0.90 ± 0.06 | .012* | A/D: .019, C/D: .002 |
| Hippocampus L | 0.58 ± 0.07 | 0.54 ± 0.05 | 0.55 ± 0.04 | 0.50 ± 0.04 | .057 | A/D: .015, C/D: .040 |
| Amygdala_L | 0.64 ± 0.09 | 0.59 ± 0.05 | 0.59 ± 0.04 | 0.55 ± 0.05 | .028* | A/D: .012, B/D: .058, C/D: .030 |
| Cuneus_R | 0.91 ± 0.08 | 0.95 ± 0.03 | 0.89 ± 0.07 | 0.98 ± 0.06 | .034* | A/D: .058, B/C: .040, C/D: .010 |
| Lingual_L | 0.85 ± 0.07 | 0.91 ± 0.05 | 0.81 ± 0.06 | 0.88 ± 0.05 | .012* | A/B: .037, B/C: .003, C/D: .065 |
| Lingual_R | 0.85 ± 0.06 | 0.90 ± 0.05 | 0.81 ± 0.06 | 0.88 ± 0.05 | .006* | A/B: .040, B/C: .003, C/D: .011 |
| Superior occipital R | 0.83 ± 0.09 | 0.84 ± 0.06 | 0.76 ± 0.05 | 0.82 ± 0.06 | .055* | B/C: .007, C/D: .030 |
| Mid occipital L | 0.85 ± 0.08 | 0.89 ± 0.05 | 0.80 ± 0.05 | 0.88 ± 0.05 | .015* | B/C: .002, C/D: .005 |
| Inferior occipital L | 0.79 ± 0.08 | 0.82 ± 0.05 | 0.74 ± 0.06 | 0.82 ± 0.05 | .030* | B/C: .005, C/D: .011 |
| Inferior occipital R | 0.82 ± 0.09 | 0.85 ± 0.05 | 0.76 ± 0.06 | 0.82 ± 0.04 | .037* | B/C: .007, C/D: .016 |
| Superior parietal L | 0.83 ± 0.08 | 0.82 ± 0.06 | 0.78 ± 0.04 | 0.87 ± 0.08 | .050* | C/D: .006 |
| Inferior parietal L | 0.85 ± 0.09 | 0.87 ± 0.04 | 0.83 ± 0.05 | 0.92 ± 0.08 | .049* | A/D: .054, C/D: .011 |
| Striatum L | 1.08 ± 0.10 | 1.07 ± 0.06 | 1.08 ± 0.07 | 0.98 ± 0.06 | .021* | A/D: .034, B/D: .009, C/D: .007 |
| Striatum R | 1.06 ± 0.09 | 1.05 ± 0.05 | 1.05 ± 0.07 | 0.98 ± 0.06 | .050* | A/D: .041, B/D: .014, C/D: .030 |
| Substantia nigra L | 0.82 ± 0.07 | 0.82 ± 0.07 | 0.86 ± 0.03 | 0.77 ± 0.04 | .006* | A/D: .028, C/D: .000 |
| Substantia nigra R | 0.84 ± 0.06 | 0.79 ± 0.07 | 0.85 ± 0.04 | 0.78 ± 0.05 | .025* | A/D: .028, B/C: .033, C/D: .016 |
| Basal ganglia L | 1.02 ± 0.07 | 1.01 ± 0.05 | 1.03 ± 0.05 | 0.93 ± 0.05 | .007* | A/D: .010, B/D: .012, C/D: .002 |
| Basal ganglia R | 1.01 ± 0.07 | 1.00 ± 0.05 | 1.01 ± 0.06 | 0.93 ± 0.05 | .016* | A/D: .010, B/D: .012, C/D: .009 |
| Thalamus L | 0.99 ± 0.03 | 0.97 ± 0.06 | 1.00 ± 0.05 | 0.91 ± 0.06 | .009* | A/D: .005, B/D: .058, C/D: .002 |
| Thalamus R | 0.99 ± 0.04 | 0.98 ± 0.06 | 1.02 ± 0.07 | 0.90 ± 0.06 | .004* | A/D: .004, B/D: .015, C/D: .003 |
*P < .05. Group A, S+N+C: schizophrenia and narcolepsy type 1, the dual diagnoses group; group B, N+C, narcolepsy type 1, the narcolepsy group; group C, S: schizophrenia, the schizophrenia group; group D, normal: healthy control, the healthy control group. L = left, R = right.